These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 22402892)
1. Cerebrospinal fluid levels of Aβ42 relationship with cholinergic cortical activity in Alzheimer's disease patients. Martorana A; Esposito Z; Di Lorenzo F; Giacobbe V; Sancesario GM; Bucchi G; Bonnì S; Bernardini S; Sorge R; Sancesario G; Bernardi G; Caltagirone C; Koch G J Neural Transm (Vienna); 2012 Jul; 119(7):771-8. PubMed ID: 22402892 [TBL] [Abstract][Full Text] [Related]
2. Self-reported traumatic brain injury and in vivo measure of AD-vulnerable cortical thickness and AD-related biomarkers in the ADNI cohort. Wang ML; Wei XE; Yu MM; Li PY; Li WB; Neurosci Lett; 2017 Aug; 655():115-120. PubMed ID: 28689050 [TBL] [Abstract][Full Text] [Related]
3. Time Trends of Cerebrospinal Fluid Biomarkers of Neurodegeneration in Idiopathic Normal Pressure Hydrocephalus. Lukkarinen H; Tesseur I; Pemberton D; Van Der Ark P; Timmers M; Slemmon R; Janssens L; Streffer J; Van Nueten L; Bottelbergs A; Rauramaa T; Koivisto AM; Herukka SK; Korhonen VE; Junkkari A; Hiltunen M; Engelborghs S; Blennow K; Zetterberg H; Kolb HC; Leinonen V J Alzheimers Dis; 2021; 80(4):1629-1642. PubMed ID: 33720890 [TBL] [Abstract][Full Text] [Related]
4. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets. Falcon C; Tucholka A; Monté-Rubio GC; Cacciaglia R; Operto G; Rami L; Gispert JD; Molinuevo JL; Neuroimage Clin; 2018; 19():190-201. PubMed ID: 30023169 [TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid biomarkers distinguish postmortem-confirmed Alzheimer's disease from other dementias and healthy controls in the OPTIMA cohort. Seeburger JL; Holder DJ; Combrinck M; Joachim C; Laterza O; Tanen M; Dallob A; Chappell D; Snyder K; Flynn M; Simon A; Modur V; Potter WZ; Wilcock G; Savage MJ; Smith AD J Alzheimers Dis; 2015; 44(2):525-39. PubMed ID: 25391385 [TBL] [Abstract][Full Text] [Related]
6. Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model. Krance SH; Cogo-Moreira H; Rabin JS; Black SE; Swardfager W; J Neurosci; 2019 Sep; 39(37):7428-7437. PubMed ID: 31350262 [TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease. Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O; JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367 [TBL] [Abstract][Full Text] [Related]
8. Additional use of Aβ₄₂/Aβ₄₀ ratio with cerebrospinal fluid biomarkers P-tau and Aβ₄₂ increases the level of evidence of Alzheimer's disease pathophysiological process in routine practice. Sauvée M; DidierLaurent G; Latarche C; Escanyé MC; Olivier JL; Malaplate-Armand C J Alzheimers Dis; 2014; 41(2):377-86. PubMed ID: 24614902 [TBL] [Abstract][Full Text] [Related]
9. Effect of Cognitive Reserve on Age-Related Changes in Cerebrospinal Fluid Biomarkers of Alzheimer Disease. Almeida RP; Schultz SA; Austin BP; Boots EA; Dowling NM; Gleason CE; Bendlin BB; Sager MA; Hermann BP; Zetterberg H; Carlsson CM; Johnson SC; Asthana S; Okonkwo OC JAMA Neurol; 2015 Jun; 72(6):699-706. PubMed ID: 25893879 [TBL] [Abstract][Full Text] [Related]
10. Decreased cerebrospinal fluid neuronal pentraxin receptor is associated with PET-Aβ load and cerebrospinal fluid Aβ in a pilot study of Alzheimer's disease. Lim B; Fowler C; Li QX; Rowe C; Dhiman K; Gupta VB; Masters CL; Doecke JD; Martins RN; Collins S; Diamandis EP Neurosci Lett; 2020 Jul; 731():135078. PubMed ID: 32450185 [TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid biomarkers of Alzheimer's disease in Chinese patients: a pilot study. Shea YF; Chu LW; Zhou L; Li WM; Lin OY; Chan MN; Xu A; Wong R; Ho TY; Liu KW; Ha J; Daniel TW; Song YQ; Lam KS Am J Alzheimers Dis Other Demen; 2013 Dec; 28(8):769-75. PubMed ID: 24085246 [TBL] [Abstract][Full Text] [Related]
12. Amyloid PETs are commonly negative in suspected Alzheimer's disease with an increase in CSF phosphorylated-tau protein concentration but an Aβ42 concentration in the very high range: a prospective study. Manca C; Rivasseau Jonveaux T; Roch V; Marie PY; Karcher G; Lamiral Z; Malaplate C; Verger A J Neurol; 2019 Jul; 266(7):1685-1692. PubMed ID: 30963253 [TBL] [Abstract][Full Text] [Related]
13. Cardiorespiratory Fitness Modifies Influence of Sleep Problems on Cerebrospinal Fluid Biomarkers in an At-Risk Cohort. Law LL; Sprecher KE; Dougherty RJ; Edwards DF; Koscik RL; Gallagher CL; Carlsson CM; Zetterberg H; Blennow K; Asthana S; Sager MA; Hermann BP; Johnson SC; Cook DB; Bendlin BB; Okonkwo OC J Alzheimers Dis; 2019; 69(1):111-121. PubMed ID: 30958346 [TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid levels of β-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia. Buchhave P; Minthon L; Zetterberg H; Wallin AK; Blennow K; Hansson O Arch Gen Psychiatry; 2012 Jan; 69(1):98-106. PubMed ID: 22213792 [TBL] [Abstract][Full Text] [Related]
15. Cystatin C levels are positively correlated with both Abeta42 and tau levels in cerebrospinal fluid in persons with Alzheimer's disease, mild cognitive impairment, and healthy controls. Sundelöf J; Sundström J; Hansson O; Eriksdotter-Jönhagen M; Giedraitis V; Larsson A; Degerman-Gunnarsson M; Ingelsson M; Minthon L; Blennow K; Kilander L; Basun H; Lannfelt L J Alzheimers Dis; 2010; 21(2):471-8. PubMed ID: 20555147 [TBL] [Abstract][Full Text] [Related]
16. Different cerebrospinal fluid levels of Alzheimer-type biomarker Aβ42 between general paresis and asymptomatic neurosyphilis. Luo X; Shi H; Hou L; Zhong X; Chen X; Zhang Y; Zheng D; Tan Y; Hu G; Mu N; Chen J; Fang Y; He H; Ning Y Eur J Neurol; 2015 May; 22(5):853-8. PubMed ID: 25707998 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic Accuracy of a Combined Analysis of Cerebrospinal Fluid t-PrP, t-tau, p-tau, and Aβ42 in the Differential Diagnosis of Creutzfeldt-Jakob Disease from Alzheimer's Disease with Emphasis on Atypical Disease Variants. Abu Rumeileh S; Lattanzio F; Stanzani Maserati M; Rizzi R; Capellari S; Parchi P J Alzheimers Dis; 2017; 55(4):1471-1480. PubMed ID: 27886009 [TBL] [Abstract][Full Text] [Related]
18. The relationship between CSF biomarkers and cerebral metabolism in early-onset Alzheimer's disease. Jaillard A; Vanhoutte M; Maureille A; Schraen S; Skrobala E; Delbeuck X; Rollin-Sillaire A; Pasquier F; Bombois S; Semah F Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):324-333. PubMed ID: 30155553 [TBL] [Abstract][Full Text] [Related]
20. The association between biomarkers in cerebrospinal fluid and structural changes in the brain in patients with Alzheimer's disease. Li X; Li TQ; Andreasen N; Wiberg MK; Westman E; Wahlund LO J Intern Med; 2014 Apr; 275(4):418-27. PubMed ID: 24237038 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]